NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
CEO Michael H. Davidson sold $10.6M of NewAmsterdam Pharma Company N.V.
Sold$10,575,091
$34.53Price
306,293Shares
−40%Stake
What NAMS did after the filing
- The stock from Fri, Feb 27 open, $33.41
- +8.5%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Apr 13 close.
Traded Tue, Feb 24. Filed Thu, Feb 26, 4:40 PM ET, after the close. Returns use the Feb 27 open and the Apr 13 close. Not investment advice.